HI
ANIP icon

Horizon Investments’s ANI Pharmaceuticals ANIP Stock Holding History

Horizon Investments’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$724K Buy
+9,419
New +$735K 0.01% 763
2025
Q4 		– Sell
-5,960
Closed -$546K – 1306
2025
Q3 		$546K Buy
+5,960
New +$486K 0.01% 805

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Horizon Investments's ANIP Position: Q1 2026 in Review

Horizon Investments opened a new position in ANI Pharmaceuticals (ANIP) in Q1 2026: 9,419 shares worth $724K. The stake represents 0.01% of the portfolio and ranks #763 among its holdings. This is a return to the name: Horizon Investments previously reported a position in ANIP as recently as Q3 2025.

Horizon Investments first reported a position in ANIP in Q3 2025 and has held it in 2 quarters since. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Horizon Investments held 9,419 shares of ANI Pharmaceuticals worth $724K as of Q1 2026.
  • ANI Pharmaceuticals was a new Horizon Investments position in Q1 2026.
  • ANI Pharmaceuticals made up 0.01% of Horizon Investments's portfolio in Q1 2026, its #763 holding.
  • Horizon Investments first reported a position in ANI Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Horizon Investments's 13F filing for Q1 2026, filed 15 May 2026.